US 12,274,779 B2
Effervescent oral composition
Anthony Richard Gerardi, Winston-Salem, NC (US); Ross Jay Oden, Winston-Salem, NC (US); Matthew Evan Lampe, Winston-Salem, NC (US); Kristen Ann Spielbauer, Kernersville, NC (US); Nicolas von Cosmos, Moravian Falls, NC (US); and Michael Andrew Zawadzki, Durham, NC (US)
Assigned to NICOVENTURES TRADING LIMITED, London (GB)
Filed by NICOVENTURES TRADING LIMITED, London (GB)
Filed on Jun. 7, 2021, as Appl. No. 17/340,621.
Application 17/340,621 is a continuation of application No. PCT/IB2021/054880, filed on Jun. 3, 2021.
Claims priority of provisional application 63/036,251, filed on Jun. 8, 2020.
Prior Publication US 2021/0378948 A1, Dec. 9, 2021
Int. Cl. A61K 9/46 (2006.01); A23L 29/00 (2016.01); A23L 29/30 (2016.01); A23L 33/105 (2016.01); A23L 33/125 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A23L 33/175 (2016.01); A24B 13/00 (2006.01); A24B 15/16 (2020.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/198 (2006.01); A61K 31/375 (2006.01); A61K 31/522 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01)
CPC A61K 9/0007 (2013.01) [A23L 29/015 (2016.08); A23L 29/035 (2016.08); A23L 29/045 (2016.08); A23L 29/37 (2016.08); A23L 33/105 (2016.08); A23L 33/125 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A24B 13/00 (2013.01); A24B 15/16 (2013.01); A61K 9/0053 (2013.01); A61K 9/009 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 31/198 (2013.01); A61K 31/375 (2013.01); A61K 31/522 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A23V 2002/00 (2013.01)] 38 Claims
 
1. An effervescent composition adapted for oral use, comprising:
an effervescent material capable of causing effervescence in the oral cavity, wherein the effervescent material has a particle size of less than about 180 microns;
one or more fillers in a total amount of at least about 30% by weight, based on the total weight of the composition, wherein the one or more fillers includes at least one sugar alcohol, and wherein a particle size of the one or more fillers is less than about 35 microns;
at least one active ingredient; and
optionally, a lipid in an amount of at least about 20% by weight.